Literature DB >> 8618672

Neuropsychological functioning in cortical-basal ganglionic degeneration: Differentiation from Alzheimer's disease.

P J Massman1, K T Kreiter, J Jankovic, R S Doody.   

Abstract

Patients with cortical-basal ganglionic degeneration (CBGD) display prominent rigidity and apraxia, exhibit an asymmetric onset of symptoms, and may show other symptoms including abnormal saccadic eye movements, the "alien limb" sign, limb dystonia, and myoclonus. We compared the neuropsychological test performances of 21 CBGD patients with 21 Alzheimer's disease (AD) patients displaying no extrapyramidal symptoms and with 12 ADA patients who did show such symptoms. Groups were matched for age, educational level, and overall severity of dementia. Since the cognitive deficit was mild in most CBGD patients, most AD patients included in this study were also only mildly demented. The CBGD patients performed significantly better than the AD patients on test of immediate and delayed recall of verbal material; whereas the AD patients (with or without extrapyramidal symptoms) performed better on tests of praxis, finger tapping speed, and motor programming. The CBGD and AD groups all displayed prominent deficits on tests of sustained attention/mental control and verbal fluency, and exhibited mild deficits on confrontation naming. The CBGD patients endorsed significantly more depressive symptoms on the Geriatric Depression Scale.

Entities:  

Mesh:

Year:  1996        PMID: 8618672     DOI: 10.1212/wnl.46.3.720

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  Dyspraxia in a patient with corticobasal degeneration: the role of visual and tactile inputs to action.

Authors:  N L Graham; A Zeman; A W Young; K Patterson; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

2.  Neuropsychological and neuroimaging correlates in corticobasal degeneration.

Authors:  E Frasson; G Moretto; A Beltramello; N Smania; M Pampanin; C Stegagno; R Tanel; N Rizzuto
Journal:  Ital J Neurol Sci       Date:  1998-10

3.  Apathy in corticobasal degeneration: possible parietal involvement.

Authors:  Rita Moretti; R Caberlotto; R Signori
Journal:  Funct Neurol       Date:  2017 Oct/Dec

4.  Symmetric corticobasal degeneration (S-CBD).

Authors:  Anhar Hassan; Jennifer L Whitwell; Bradley F Boeve; Clifford R Jack; Joseph E Parisi; Dennis W Dickson; Keith A Josephs
Journal:  Parkinsonism Relat Disord       Date:  2009-12-16       Impact factor: 4.891

5.  Differentiating cognitive impairment due to corticobasal degeneration and Alzheimer disease.

Authors:  Gregory S Day; Tae Sung Lim; Jason Hassenstab; Alison M Goate; Elizabeth A Grant; Catherine M Roe; Nigel J Cairns; John C Morris
Journal:  Neurology       Date:  2017-02-24       Impact factor: 9.910

6.  Application of Choynowski's Memory Scale in assessment of patients with dementia.

Authors:  Konrad Janowski; Katarzyna Gustaw; Małgorzata Kasprowicz
Journal:  Arch Med Sci       Date:  2012-02-29       Impact factor: 3.318

7.  Clinicopathologic analysis of progressive non-fluent aphasia and corticobasal degeneration: Case report and review.

Authors:  Paulo Roberto de Brito-Marques; Roberto José Vieira-Mello; Luciano Montenegro; Maria de Fátima Vasco Aragão
Journal:  Dement Neuropsychol       Date:  2011 Apr-Jun

Review 8.  Language impairment in progressive supranuclear palsy and corticobasal syndrome.

Authors:  Katie A Peterson; Karalyn Patterson; James B Rowe
Journal:  J Neurol       Date:  2019-07-18       Impact factor: 4.849

9.  Severe episodic memory impairment in a patient with clinical features compatible with corticobasal degeneration.

Authors:  Sung Kwan Kim; Kyung Won Park; Do-Young Kang; Jae Kwan Cha; Sang-Ho Kim; Jae Woo Kim
Journal:  J Clin Neurol       Date:  2008-06-20       Impact factor: 3.077

Review 10.  Oculo-Visual Dysfunction in Parkinson's Disease.

Authors:  R A Armstrong
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.